Related Experiment Videos
[Mapping electrocardiographic fields in heart hypertrophy]
K Kozlíková1, Z Balázsiová, J Murín
1Ustav lekárskej fyziky a biofyziky Lekárskej fakulty Univerzity Komenského, Bratislava, Slovak Republic. kozlikova@fmed.uniba.sk
Sbornik Lekarsky
|May 10, 2000
Summary
This study analyzed electrocardiographic map parameters for diagnosing heart hypertrophy. These parameters were effective in tracking the regression of left ventricular hypertrophy after verapamil treatment.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Context:
- Left ventricular hypertrophy (LVH) is a significant cardiovascular condition.
- Body surface electrocardiographic mapping offers a non-invasive method for cardiac assessment.
- Treatment response monitoring is crucial for managing LVH.
Purpose:
- To evaluate specific electrocardiographic map parameters for diagnosing heart hypertrophy.
- To assess the utility of these parameters in monitoring treatment-induced regression of LVH.
- To analyze changes in these parameters following verapamil therapy.
Summary:
- The study focused on parameters derived from body surface electrocardiographic maps for heart hypertrophy diagnosis.
- Repeated measurements were taken from a patient with left ventricular hypertrophy.
- Observed regression of hypertrophy after verapamil treatment was analyzed using these parameters.
Impact:
- Provides insights into non-invasive diagnostic markers for heart hypertrophy.
- Demonstrates the potential of electrocardiographic mapping in tracking therapeutic interventions.
- Contributes to understanding the physiological changes associated with verapamil treatment in LVH.